Detalhe da pesquisa
1.
Impact of BRICS' investment in vaccine development on the global vaccine market.
Bull World Health Organ
; 92(6): 436-46, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24940018
2.
WHO policy development processes for a new vaccine: case study of malaria vaccines.
Malar J
; 9: 182, 2010 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20576114
3.
Development of priority vaccines for disease-endemic countries: risk and benefit.
Health Aff (Millwood)
; 24(3): 718-28, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15886166
4.
Emergency response vaccines: lessons learned in response to communicable diseases.
Expert Opin Biol Ther
; 3(7): 1121-31, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14519076
5.
Immunization safety priority project at the World Health Organization.
Semin Pediatr Infect Dis
; 14(3): 233-9, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12913836
6.
Regulation of vaccines: strengthening the science base.
J Public Health Policy
; 25(2): 173-89; discussion 190-6, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15255384
7.
Tools and approaches to ensure quality of vaccines throughout the cold chain.
Expert Rev Vaccines
; 13(7): 843-54, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24865112
8.
Global support for new vaccine implementation in middle-income countries.
Vaccine
; 31 Suppl 2: B81-96, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598496
9.
Development of new tuberculosis vaccines: a global perspective on regulatory issues.
PLoS Med
; 4(8): e252, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17683198
10.
The role of emerging manufacturers in access to innovative vaccines of public health importance.
Vaccine
; 28(9): 2115-21, 2010 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20044054
11.
Regulatory pathways for developing market vaccines.
Expert Rev Vaccines
; 2(5): 599-601, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14711319
12.
Reaching international GMP standards for vaccine production: challenges for developing countries.
Expert Rev Vaccines
; 8(5): 559-66, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19397413
13.
The GO License: only part of the solution.
Health Aff (Millwood)
; 27(1): 140-2, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18180489
14.
The GAVI Financing Task Force: one model of partner collaboration.
Vaccine
; 26(51): 6699-705, 2008 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19306508
15.
Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.
Vaccine
; 26(51): 6717-26, 2008 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-18955100
16.
Access to vaccine technologies in developing countries: Brazil and India.
Vaccine
; 25(44): 7610-9, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17913312
17.
Managing the effect of TRIPS on availability of priority vaccines.
Bull World Health Organ
; 84(5): 360-5, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16710544
18.
The impact of globalization on vaccine development and availability.
Health Aff (Millwood)
; 25(4): 1061-9, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16835187
19.
Regulatory pathways for vaccines for developing countries.
Bull World Health Organ
; 82(2): 128-33, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15042235
20.
Emergency response vaccines--a challenge for the public sector and the vaccine industry.
Vaccine
; 21(1-2): 146-54, 2002 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-12443673